KLOW is a composite peptide blend formulated for research applications involving tissue integrity, inflammation signaling, and cellular repair mechanisms. It contains four well-studied peptides—TB-500, BPC-157, KPV, and GHK-Cu—each with distinct but complementary biological activity profiles that have been explored extensively in preclinical and molecular research.
TB-500, a synthetic fragment of thymosin beta-4, is widely researched for its involvement in cell migration, angiogenesis, and cytoskeletal organization. BPC-157 is a gastric-derived peptide commonly examined for its effects on connective tissue signaling, vascular response, and cellular protection pathways. KPV, a tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH), is studied for its regulatory role in inflammatory signaling, particularly through modulation of NF-κB–related pathways. GHK-Cu is a naturally occurring copper peptide researched for its influence on gene expression, collagen synthesis, and tissue remodeling processes.
In research contexts, KLOW is used to explore how multiple regenerative and regulatory peptides may interact within complex biological systems. Investigation typically focuses on molecular signaling, cellular communication, and tissue-level responses rather than therapeutic or clinical application.
